CD19 and polycystic ovary syndrome: Our previous studies demonstrated that the peripheral proportion and activity of CD19+ B cells were increased in women with PCOS and dehydroepiandrosterone (DHEA)-induced morphological changes to mouse ovaries were prevented by CD19+ B cell depletion (Xiao et al., 2019), demonstrating that CD19+ B cells contribute to the pathogenesis of PCOS.